Advanced Parkinson's Disease
Showing 1 - 25 of >10,000
Subthalamic Deep Brain Stimulation in Advanced Parkinson's
Active, not recruiting
- Parkinson Disease
-
Helsinki, FinlandDepartment of Neurology and department of Neurosurgery Helsinki
Oct 18, 2023
Subcutaneous Infusion of ABBV-951 to Assess Change in Disease
Not yet recruiting
- Parkinson's Disease (PD)
- (no location specified)
Jun 15, 2023
Parkinson Disease Trial (Vibrotactile coordinated reset)
Not yet recruiting
- Parkinson Disease
- Vibrotactile coordinated reset
-
Stanford, CaliforniaStanford University
Dec 5, 2022
AADC/TDC in Advanced Parkinson's Disease
Not yet recruiting
- Parkinson Disease
- (no location specified)
Dec 9, 2022
Parkinson Disease Trial in Jinan (STN-DBS)
Completed
- Parkinson Disease
- STN-DBS
-
Jinan, Sichuan, ChinaChao Zhang
Oct 15, 2023
Parkinson's Disease Trial in Changsha (BBM-P002)
Not yet recruiting
- Parkinson's Disease
-
Changsha, Hunan, ChinaXiangya Hospital of Central South University
Apr 9, 2023
Parkinson Disease Trial in Helsinki
Active, not recruiting
- Parkinson Disease
-
Helsinki, FinlandHUH Meilahti Hospital, department of neurology
May 23, 2022
Parkinson's Disease Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Convection enhanced
Completed
- Parkinson's Disease
- Convection enhanced delivery/AAV2-GDNF
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Advanced Parkinson's Disease Trial in Orange, New York, Toronto (MSK-DA01, MSK-DA01 Cell Delivery Device)
Active, not recruiting
- Advanced Parkinson's Disease
- MSK-DA01
- MSK-DA01 Cell Delivery Device
-
Orange, California
- +2 more
May 31, 2022
Stellate Ganglion, Parkinson Disease Trial in Guangzhou (Treatment (Stellate ganglion block;Oral standard anti-Parkinson's
Recruiting
- Stellate Ganglion
- Parkinson Disease
- Treatment (Stellate ganglion block;Oral standard anti-Parkinson's drugs)
- Treatment (Oral standard anti-Parkinson's drugs)
-
Guangzhou, Guangdong, ChinaZhujiang Hospiatal
Oct 26, 2023
Advanced Parkinson's Disease Trial in United States (Sinemet, IPX203)
Completed
- Advanced Parkinson's Disease
-
Little Rock, Arkansas
- +10 more
May 11, 2022
Parkinson Disease Trial in Hangzhou (KL002 injection solution)
Not yet recruiting
- Parkinson Disease
- KL002 injection solution
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital of Zhejiang University School of Medi
May 22, 2023
Parkinson's Disease Trial in Amsterdam (Continuous intrajejunal infusion of levodopa-carbidopa, deep brain stimulation)
Active, not recruiting
- Parkinson's Disease
- Continuous intrajejunal infusion of levodopa-carbidopa
- deep brain stimulation
-
Amsterdam, Noord Holland, NetherlandsAcademic Medical Center
Apr 20, 2022
ABBV-951 Subcutaneous Infusion to Assess Change in Disease
Not yet recruiting
- Parkinson's Disease (PD)
- (no location specified)
Oct 25, 2023
Parkinson Disease Trial in Aurora (Low-load resistance training with blood flow restriction)
Recruiting
- Parkinson Disease
- Low-load resistance training with blood flow restriction
-
Aurora, ColoradoUniversity of Colorado
Apr 13, 2023
Parkinson's Disease and Parkinsonism Trial in Calgary (Tailored Support Group)
Not yet recruiting
- Parkinson's Disease and Parkinsonism
- Tailored Support Group
-
Calgary, Alberta, CanadaHealth Science Centre, University of Calgary
Oct 10, 2023
Parkinson Disease Trial in Rome (Standard LD/CD, Semi continuous intra-oral administration of LD/CD)
Completed
- Parkinson Disease
- Standard LD/CD
- Semi continuous intra-oral administration of LD/CD
-
Rome, ItalyIrccs San Raffaele Pisana
Oct 17, 2022
Parkinson Disease Trial in Cairo (Zonisamide Capsules)
Recruiting
- Parkinson Disease
- Zonisamide Capsules
-
Cairo, Abbasia, Egypt
- +1 more
Oct 3, 2021
DiSCERN: Advanced PD Therapy Candidacy and Evaluation System
Recruiting
- Parkinson Disease
- DiSCERN
-
Cincinnati, Ohio
- +1 more
Aug 1, 2022
Parkinson's Disease Trial in Worldwide (ND0612 (Levodopa/Carbidopa solution), ND0612 (Levodopa/Carbidopa solution) + morning
Completed
- Parkinson's Disease
- ND0612 (Levodopa/Carbidopa solution)
- ND0612 (Levodopa/Carbidopa solution) + morning oral IR-LD/CD
-
Chicago, Illinois
- +10 more
Feb 16, 2022
Idiopathic Parkinson's Disease, Parkinson's Disease, Basal Ganglia Disease Trial in United States (VY-AADC01)
Completed
- Idiopathic Parkinson's Disease
- +8 more
-
San Francisco, California
- +3 more
Mar 17, 2022
Parkinson's Disease Trial in Charlottesville (ExAblate Transcranial System)
Active, not recruiting
- Parkinson's Disease
- ExAblate Transcranial System
-
Charlottesville, VirginiaUniversity of Virginia
Dec 19, 2022
Handwriting Analysis in Movement Disorders
Not yet recruiting
- Movement Disorders
- +2 more
- (no location specified)
Sep 26, 2022
Advanced Parkinson's Disease Trial (Levodopa-Carbidopa Intestinal Gel, Percutaneous Endoscopic Gastrostomy with Jejunal
Completed
- Advanced Parkinson's Disease
- Levodopa-Carbidopa Intestinal Gel
- +2 more
- (no location specified)
Jul 14, 2021